Back
ESC Premium Access

Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

Session: Poster Session 5 - Mechanisms underlying pharmacotherapy
Topic: Antidiabetic Pharmacotherapy
Speaker: Doctor P. Nikolaou (Athens, GR)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Panagiota Efstathia Nikolaou

National & Kapodistrian University of Athens, Athens (Greece)
1 follower

6 more presentations in this session

microRNA-17-5p and microRNA-20a-5p downregulation by atorvastatin in Hepg2 cells: a new mechanism involved in the lipid-lowering therapy

Speaker: Assistant Professor K. Saavedra (Temuco, CL)

Access
Abstract
Like
Thumbnail

Atorvastatin and fenofibrate exert opposite effects on the vascularization and characteristics of visceral adipose tissue

Speaker: Doctor O. Perez-Mendez (Mexico City, MX)

Access
Abstract
Slides
Like
Thumbnail

The pineal hormone melatonin inhibits doxorubicin-induced mitochondrial dysfunction and apoptosis in cardiomyocytes

Speaker: Miss T. Kasi Ganeshan (London, GB)

Access
Abstract
Like
Thumbnail

Significative role of edoxaban on endotelial cell functions

Speaker: Miss C. Almenglo (Santiago de Compostela, ES)

Access
Abstract
Slides
Like
Thumbnail

Acute Cardio-Selective Functional Modulation via a Small-Molecule Direct Myosin-Attenuator (MYK-581) Preserves Diaphragmatic Function in vivo: Comparison versus Disopyramide

Speaker: Doctor C. del Rio (Brisbane, US)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 5 - Mechanisms underlying pharmacotherapy

Speakers: Doctor P. Nikolaou, Assistant Professor K. Saavedra, Doctor O. Perez-Mendez, Miss T. Kasi Ganeshan, Miss C. Almenglo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources